ArticleNPJ digital medicine2026
Distinction between primary and metastatic mucinous ovarian carcinoma from histopathology images using deep learning.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Accurately distinguishing between primary and gastrointestinal metastatic mucinous ovarian carcinoma (MOC) is crucial but remains highly challenging. We developed and validated the MOC Origin Prediction Model (MOCOPM), the deep learning model specifically designed to predict the origin of MOC from histopathology images. Cases of primary or gastrointestinal metastatic MOC were collected from three hospitals and divided into internal and external cohorts. Three neural networks were trained using the area under the receiver operating characteristic curve (AUROC) as the primary performance metric. After five-fold cross-validation on the internal cohort, the best-performing model was selected to construct MOCOPM, which was then externally validated. In total, 167 MOC patients were included. MOCOPM achieved an average AUROC of 0.91 internally and 0.96 externally. This model offers a promising tool to support clinical decision-making in MOC diagnosis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.